Symbol: |
GPR162
|
Description: |
G protein-coupled receptor 162 [Source:HGNC Symbol;Acc:16693]
|
Location: |
Chr12:6930711-6936586[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:129
Gene |
Compound |
Gen_sig |
Exp_pattern |
GPR162 |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.004 |
Up |
GPR162 |
NSC 408470 |
0.033 |
Down |
GPR162 |
Morpholine-N-dithiocarbamate |
0.019 |
Down |
GPR162 |
9,10-o-Benzenoanthracene-1,4-dione, 2,3-dichloro-9,10-dihydro- |
0.021 |
Up |
GPR162 |
C.I. 37559 |
0.025 |
Up |
GPR162 |
Veracoquinazole |
0.026 |
Up |
GPR162 |
Camptothecin ethylglycinate ester hydrochloride |
0.036 |
Up |
GPR162 |
RAPAMYCIN PRODRUG |
0.007 |
Up |
GPR162 |
Camptothecin lysinate HCl |
0.009 |
Up |
GPR162 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.033 |
Up |
GPR162 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.017 |
Up |
GPR162 |
4H-1-Benzothiopyran-4-one, 2-(methylsulfinyl)- |
0.044 |
Down |
GPR162 |
9-AMINO-20-CAMPTOTHECIN |
0.005 |
Up |
GPR162 |
cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) |
0.043 |
Down |
GPR162 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.006 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:7
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|